MALDI-TOF mass spectrometry is increasingly being applied as a clinical research tool in biomarker discovery, clinical proteomics, functional genomics, molecular imaging, and microorganism ...
Bruker said today that it launched the second phase of an ongoing collaboration with SISCAPA Assays Technologies (SAT), intended to exploit the high throughput, robustness, and ease of use of ...
Bruker Announces Multiple Placements of MALDI Biotyper Systems with Various German Federal, State an
BREMEN, Germany--(BUSINESS WIRE)-- Bruker today announces multiple placements of MALDI Biotyper systems for rapid, differentiated and cost-effective microbial identification with various local, state ...
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX™ MALDI PharmaPulse™ (MPP) solution. It is the latest addition to Bruker’s portfolio of innovative products designed to ...
AMSTERDAM, April 15, 2019 /PRNewswire/ -- At the European Congress of Clinical Microbiology and Infectious Diseases (www.eccmid.org), Bruker announces new assays, software and library extensions for ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure MALDI PharmaPulse is a complete mass ...
Bruker Launches Library Update for Mycobacteria, Showcases Workflow Optimization tools like MALDI Biotyper Pilot™, MALDI Biotyper Galaxy™ and novel MSBL Software for MALDI-based Functional Resistance ...
MONTREAL--(BUSINESS WIRE)-- At the 2011 Annual Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), the companies i2A Canada and Bruker Ltd. announced ...
At the virtual ASMS 2020 Reboot conference, Bruker Corporation today announces a major advance in matrix-assisted laser desorption ionization (MALDI) with the launch of the world’s first commercial ...
neofleX is a versatile, high-performance, and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers neofleX Imaging Profiler MALDI-TOF/TOF with proprietary smartbeam ...
GENEVA--(BUSINESS WIRE)--At the 4 th Congress of European Microbiologists (FEMS 2011), Bruker announces the amendment of its exclusive distribution agreement for clinical microbiology for Bruker’s ...
The firm bought selected assets in Glasgow, UK for the development, validation and commercialization of molecular assays for applications in microbiology. It includes lab infrastructure and IP in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback